Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE (www.oxfordhandbooks.com). © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 02 June 2020

(p. 920) (p. 921) Index

(p. 920) (p. 921) Index

Note: Page references followed by “f” and “t” denote figures and tables, respectively.

12-step treatment plans, alcohol use disorders, 435, 436
AAAP (American Association for Applied Psychology), 28
ABA (Applied behavior analysis), 31, 45
ABFT (Attachment-based family therapy for depressed adolescents), 115
ABPP (American Board of Professional Psychology), 6, 59
Acamprosate (Campral), 437
Acceptance and Commitment Therapy (ACT), 179, 291
Acetylcholine muscarinic receptor (CHRM2), 418
Acquired tolerance phenomenon, 416
ACT (Acceptance and Commitment Therapy), 179, 291
Act for Licensure of Psychologists, 159
Acute hydrocephalus, 599
Acute stress disorder (ASD), 366
AD (Alzheimer disease), 570, 584, 591
Adaptive Behavior Scales-Revised, 570
Adaptive functioning, 570
Adaptive objects, internalizing, 100
Addiction Equity Act of 2008, 37
Addiction Technology Transfer Centers (ATTCs), 909
ADH1B*2 allele, 417–18
ADI-R (Autism Diagnostic Interview-Revised), 567
ADIS (Anxiety Disorder Interview Schedule), 283
ADIS-IV-L (Anxiety Disorders Interview Schedule for DSM-IV: Lifetime Version), 283
ADIS-R (Anxiety Disorders Interview Schedule -Revised), 283
Adjustment disorder, 366
Adolescents
alcohol exposure, 418
attachment-based family therapy for depressed adolescents (ABFT), 115
conduct disorder, adolescentonset type, 572
evidence-based practice (EBP) for child and adolescent behavior problems and disorders, 773–80
interpersonal psychotherapy modified for depressed adolescents (IPT-A), 55
nonsuicidal self-injurious thoughts (NSSI) and behaviors, 515
same-sex sexuality, 850–52
ADOS (Autism Diagnostic Observation Schedule), 567
Adult disorders of psychopathology, 258
African Americans, 878, 884–85
alcohol use disorders among, 414
sexual-minority population, 854
Agency for Health Care Policy and Research (AHCPR), 130
Agency for Healthcare Research and Quality (AHRQ), 15, 130
Agoraphobia (AG), 366, 774
Alcohol
dependence, 258
diagnostic criteria for alcohol dependence, 261
as drug. See Alcohol as drug
Alcohol as drug
acute effects, 414
anxiety and mood disorders, 416
anxiolytic properties, 414
biphasic effects, 415
chronic adaptation, 416
chronic adaptations, 415—16
emotional responding, 414
GABAergic mechanisms, 414
negatively reinforcing acute subjective effects, 414
positively reinforcing effects, 414
punishing acute subjective effects, 414
reinforcing effects, 416
(p. 922) role in central nervous system (CNS) neurotransmitter systems, 414
Alcohol myopia theory, 415
Alcohol use disorders (AUDs), 410–51
abuse/dependence distinction, 411, 413t
adolescence alcohol exposure, 418
affect regulation strategy, 423
alcohol outcome expectancies, 421–22
among African American men, 414
among Asians, 417
assessment of consumption, 429
binge drinking, 413, 415, 429, 432, 435
biomarkers of consumption, 430
brief interventions to reduce alcohol consumption, 433
cognitive-behavioral interventions for alcohol dependence, 433
community-based prevention efforts, 431–32
consumption patterns, 412–13
daily diary and ecological momentary assessment approaches, 429–30
definition, 410–12
diagnostic interviews, 429
DSM-IV substance use disorder criteria, 412
emerging adulthood period, 414
environment factors, 418
epidemiology, 413–14
extraversion/sociability traits, 421
family-based therapy, 435
generalized externalizing behavior problems, 423
genetic influences, 416–18
harm reduction approaches, 430
impulsive/disinhibited traits, 421
intimate partner influence, 420
item-response theory (IRT)- based analyses, 411
lack of self-regulation, 434
medical morbidity and mortality, 426–29
motivations for use, 422–23
neurocognitive deficits, 421
over life course, 414
parental influences, 419
peer influence, 419
personality traits, 421
Pharmacological Vulnerability model, 423
pharmacotherapy, 436–37
prenatal alcohol exposure, 418
prevention efforts, 430
psychiatric comorbidity, 424–29
psychometric analyses, 411
public policies on alcohol for preventing, 430
role of media, 420
school-based prevention efforts, 431
self-help groups, 436
sensation seeking behavior and, 421
server liability laws for preventing, 431
server training, 431
across subcultural groups, 420
treatment, 432–37
Alcohol withdrawal, treatment for, 432
Aldehyde dehydrogenase (ALDH), 417, 422
Allocation concealment, 139
Allostasis, 416
Alternative treatments, comparison of, 57
Alzheimer disease, 570, 584, 591
American Association for Applied Psychology (AAAP), 28
American Association of Clinical Psychologists (AACP), 27–28
American Association on Intellectual and Developmental Disabilities (AAIDD), 568
American Board of Professional Psychology (ABPP), 6, 59
American Civil Liberties Union (ACLU) Freedom of Information, 202
American Psychological Association (APA), 3, 26, 256–57
accredited doctoral programs in clinical psychology, 150
Board of Educational Affairs (BEA) Task Force, 152
Clinical Section, 27–28
Commission on Ethnic Minority Recruitment Retention and Training in Psychology (CEMRRAT), 164
Congressional Fellowship Program, 36
Graduate Students’ (APAGS) Advocacy Coordinating Team (ACT), 37
Model Act for Licensure, 159
Multicultural Guideline, 1, 882
Society of Pediatric Psychology, 86
Amitriptyline, 395
Amnestic disorders, 584
Anhedonia, 25, 241
Annapolis Coalition for the Behavioral Health Workforce report, 165
Anorexia nervosa (AN), 392
among males, 393
comorbidities, 393
impact of substance abuse and dependence, 393
morbidity and mortality, 393
prevalence, 393
restricting type (AN-R), 392
stepped-care approach, 397
treatment efficacy, 394
Anorgasmia, 456
Anosognosia, 693–94
Anticonvulsants, 528
Antipsychotics, 528
Antisocial personality disorder, 258, 264, 697
(p. 923) Anxiety-depressive disorder, 281–95
comorbidity, 284–85
diagnostic reliability, 282–83
dimensional vs. categorical classification of, 287–88
hierarchical models, 285–86
inter-rater reliability studies for DSM-IV and DSM-III-R, 284t
reliability studies, 282–83
transdiagnostic treatment approaches, 291–92
treatment of, 289–90
Anxiety Disorder Interview Schedule (ADIS), 283
Anxiety disorders, 107, 256–57
Anxiety Disorders Interview Schedule for DSM-IV: Lifetime Version (ADIS-IV-L), 283
Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV), 230, 235–36, 326
Anxiety Disorders Interview Schedule-Revised (ADIS-R), 283
Anxiety/neuroticism/behavioral inhibition (A/N), 906
Anxiety sensitivity, 286
Anxiousness, 258
Apolipoprotein E (APE-e) 4
allele, 591
Applied behavior analysis (ABA), 31, 45
Aripiprazole (Abilify), 297
Aristotle, 297
Arpilleras, 891
Arteriovenous malformations (AVMs), 583, 594
ASD (Autism spectrum disorder), 565–68
Asians, 883–85
alcohol use disorders (AUDs), 417
interpersonal orientation, 883, 890
sexual-minority population, 854
Asperger disorder, 565–66
ASPPB Model Act for Licensure of Psychologists, 159
Assertive Care and Treatment (ACT) program, 175
Assessing risk of harm to self or others. See Behavioral emergency
Association of Family and Conciliation Courts (AFCC), 80
Association of Psychology Postdoctorate and Internship Centers (APPIC), 40
internship, 155
Association of State and Provincial Psychology Licensing Boards (ASPPB), 901
Association of Veterans Affairs Psychology Leaders (AVAPL), 171
Attachment-based family therapy for depressed adolescents (ABFT), 115
Attending behavior, 244
Attention-deficit hyperactivity disorder (ADHD), 42, 303, 559–62, 583
assessment and treatment, 561
clinical description, 559
epidemiology, 559–60
etiology, 560
Attention-placebo conditions, 54–55
Augmentative communication strategies, 571
Autism Diagnostic Observation Schedule (ADOS), 567
Autism Speaks, 46
Autism spectrum disorder (ASD), 565–68
Autism spectrum disorders (ASD), 45
Autoimmune disorders, 600–601
Automatic processing, 700
Autonomic arousal, 286
Autonomic hyperarousal, 285
Axis I disorders
Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV), 230, 235–36, 326
Composite International Diagnostic Interview (CIDI), 235
Diagnostic Interview Schedule (DIS), 234
Diagnostic Interview Schedule for Children (DISC), 234–35
disorder-specific measures, 237
inter-rater reliability, 233–34
Mini-International Neuropsychiatric Interview (MINI), 237
“stem-and-branching tree” format, 234
structured and semistructured interview for, 281
Structured Clinical Interview for DSM-IV, 235–36
Axis II disorders
International Personality Disorder Examination (IPDE), 237, 239
structured and semistructured interview for, 281
Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II), 240
Structured Interview for DSM-IV Personality Disorders (SIDP-IV), 237, 240
Ayurvedic medicine, 24
Balance, 632
Barlow, David H., 212
model of anxiety and panic, 371–72
Beating the Blues, 631–32
Beck, Aaron T., 31, 219
Beck Depression Inventory (BDI), 63, 92, 548
Beck Institute, 219
Behavioral activation/positive affect (BA/P), 906
Behavioral anchors, 152
Behavioral couple therapy (BCT), 115, 799
basic concepts, 800
contribution to distress, 801
empirical support, 805
treatment approaches, 801–802
Behavioral crises vs. behavioral emergencies, 748–49
Behavioral disinhibition, 522
Behavioral emergency, 747–70
vs. behavioral crises, 748–49
coping behavior, 763–64
evaluation of risk of interpersonal victimization, 760–61
evaluation of suicide risks, 753–54
evaluation of violence risks, 756–57
evidence-based approach to, 752–53
imminent risk, 748
incidence of, 750–51
inter-relatedness, 749
management of, 751–52
patient suicidal behavior, 750
patient violent behavior, 750
patients as victims of violence, 750–51
risk management, 758, 762–63
Behavioral weight loss (BWL) treatment, 402
Behaviour Research and Therapy, 31
Benzodiazepines, 298
Bereavement, 266, 366
The Best Care Anywhere, 173
Betrayal trauma theory (BTT), 365,374–75
Between-groups designs, 56
Bicultural effectiveness training (BET), 889
Binet, Alfred, 27
Binet tests, 27
Binge drinking, 413, 415, 429, 432, 435
Binge eating disorder (BED), 143, 392
common features with other eating disorders, 402
comorbidities, 402
future directions, 405
guided self-help based on the CBT model, 402
rapid response to treatment, 404–405
treatment, 402–403
treatment-as-usual (TAU), 403
weight loss, 403
Biphobia, 859
Bipolar disorder, 296–308, 700–701
borderline personality disorder, 306
categorical considerations of spectrum, 304
cognitive behavioral therapy, 300
cyclic mood instability, 297
depression, 302
diagnostic criteria of spectrum, 303–4
early onset of, 303
factors influencing poor outcome, 302–303
family-focused therapy, 300–301
group therapy, 301–302
hard bipolar II, 304
interpersonal and social rhythm therapy, 302
likelihood of suicide attempts, 302–303
nature and course, 297
pharmacotherapy, 297–98
prevalence rates, 306–307
psychotherapy for, 302
rapid cycling course, 297
rates of relapse, 296–97
sex differences, 297
soft bipolar II, 304
subtype I, 297
subtype II, 258, 297
treatment implications, 306–7
Bisexual subtypes, 859–60 See also Sexual-minority population
Bleuler, Eugen, 481
Blood alcohol concentration (BAC), 413, 415
BluePages, 631–32
Body dysmorphic disorder (BDD)
demographic characteristics, 350
diagnostic criteria and prevalence, 350
psychosocial treatment, 351
Body Dysmorphic Disorder Examination (BDDE), 46
Borderline personality disorder (BPD), 264, 696
Boston Globe, 202
Boston Naming Test, 586
Boston Visuospatial Quantitative Battery, 586
Boulder Conference, 4, 30, 153
Boundaries ethic of, 199–200
Boundary crossing, 200
Boundary violation, 200
Bowel Symptom Severity Scale, 355
Brain tumors, 599
BRAVE for Children, 635–36
(p. 925) Brief Index of Sexual Functioning for Women (BISF-W), 453
Brief strategic family therapy (BSFT), 114
Briquet’s syndrome, 343
Brofaromine, 399
Brown Assessment of Beliefs Scale (BABS), 327
Bulimia nervosa (BN), 392
cognitive-behavior therapy, 398
comorbidities, 398
dietary restrictions, 398
family therapy, 399
future directions, 400–01
guided self-help, 399
interpersonal psychotherapy (IPT), 398–99
prevalence and incidence of, 397
treatment efficacy, 398–99
Bupropion, 298
California Institute of Mental Health (CIMH), 220
Callosal disruptions, 599
Calming techniques, 17
Campral, 437
Canadian Code of Ethics, 189–90
Canadian Psychological Association (CPA), 186
courtship disorders, 465
ethics code, 201–02
Capgras syndrome, 694
Carbamazepine, 297
Carnegie Foundation, 129
Case formulation, 111
contributions from different schools, 245–46
definition and elements, 245
elements of good, 246–47
impact of training on, 248–49
role in psychological treatment, 246
treatment efficacy, 247–49
Cathartic method, 98
Center for Anxiety and Related Disorders (CARD), 9–10
Center for Mental Health Services (CMHS), 144
Centers for Disease Control and Prevention (CDC), 35
Centers for Medicare and Medicaid Services (CMS), 35
Cerebellar disorders, 598
Cerebral aneurysms (CAs), 594–96
Cerebral autosomal dominant angiopathy with subcortical infarcts and leukoencephalopathy (CADASIL), 593, 595
Cerebrovascular disorders, 592–93
Certificate of Professional Qualifications in Psychology (CPQ), 159
Chambless, Dianne, 212
Change principles, 118–20
Changes in Sexual Functioning Questionnaire (CSFQ), 453
Charcot, Jean, 25, 29
Cherokee Health Systems, 40
Child Behavior Checklist (CBCL), 573
Children
anxiety disorders, 56
Child Behavior Checklist (CBCL), 63
childhood disintegrative disorder, 565, 568t
children of alcoholics (COAs), 419
evidence-based practice (EBP) for child and adolescent behavior problems and disorders, 773–80
pedophilia, 463
sexual abuse, 243
Chlorpromazine, 395
Chondroitin sulfate proteoglycans (CSPGs), 913
CHRM2 (Acetylcholine muscarinic receptor), 418
Chronic fatigue syndrome (CFS), 352
CIDI-Primary Health Care Version (CIDI-PHC), 235
CINAHL (Cumulative Index to Nursing and Allied Health Literature), 141
Cisapride, 395
Clarke Sex History
Questionnaire, 463
(p. 926) Classical humanistic-experiential theories of functioning, 108
Clinical interventions with children and adolescents, 771–97
advances in, 771
age factor, 780–83
anxiety disorders, 774–75
attention-deficit hyperactivity disorder, 777–78
behavior problems, 773–80
developmental context, 780–84
evidence-based treatments (EBTs), 772
implications for clinical practice, 789–92
mood disorders, 775–77
oppositional and conduct problems, 778–80
relational context, 784–88
therapeutic alliance, 784–86
Clinical interview asking questions, 244–45
attending behavior, 244
behavioral observations, 232–33
benefits, 227
body of, 230
case formulation, 245–49
client’s interpretation and response, 228
client’s presenting problems and goals, 231
closing session of, 230–31
confidentiality, 230
confirmation bias, 243
content of, 231–33
couple interview, 249–50
in emergency situations, 228
eye contact, 229
initial steps, 229
inter-rater reliability, 228
interview-based symptom measures, 238t
interviewer bias, 242–43
multi-individual, 249
multicultural, 250
90–120-degree angle seating arrangement, 229
obsessive-compulsive disorder (OCD), 326–27
open-ended question style, 231
opening phase of, 229–30
physical space, role of, 229
for purposes of long-term therapy planning, 228
role in management of psychological distress, 227
role in mental health care process, 229
seating arrangement, 229
special populations, 250–51
strategies and skills, 242–44
structure of, 229–31
structured, 228
structured, for Axis I disorders, 233–37
structured, for Axis II disorders, 237–39
suicide risk assessment, 240–42
therapeutic relationship, 228
treatment history, 232
unstructured, 228, 231
of young clients, 251
Clinical neuropsychology, 688–708
anxiety disorders, 702–703
base rate for assessment, 691
board certification, 689
formal organizations, 688–89
history of, 688–89
medial frontal cortex deficits, 693
mood disorders, 700–701
neuropsychological evaluations, 689–90
orbitofrontal cortex deficits, 693
psychological disorders, 696–97
repeat assessment/practice effects, 691–92
somatoform disorders, 698–700
symptom exaggeration/ examinee’s effort, 692
symptoms associated with neurological conditions, 693–95
training issues, 689
treatment of psychiatric disorders, 703–704
treatment of symptoms, 695–96
Clinical psychologists as health-service providers, 162–63
Clinical replication, 908
Clinical significance, 63
Clinical training, joint training in practice and research, 5
Clinical utility, concept of, 81, 92
Clomipramine, 395
Clonidine, 395
Closed questions, 244
Clozapine, 528
Co-located mental health provider, 175
Coca Cola project, 28
Cochrane, Archibald, 129
Cochrane Collaboration, 129
Cochrane Controlled Clinical Trials Registry, 141
Cochrane Database of Systematic Reviews, 141
Cognitive ability testing, 262
Cognitive-Behavioral Coping Skills, 433–34
Cognitive-behavioral couple therapy (CBCT)
approaches, 804
basic concepts, 802–804
contributions, 803
empirical support, 805–806
Cognitive-behavioral therapy (CBT), 17, 54, 56, 66, 179, 219, 247, 292, 354–55, 880
basic focus in, 106
for BED, 404
for bipolar disorder, 299–300
broad, 401
for bulimia nervosa (BN), 398
(p. 927) for child anxiety disorders, 785
context of problematic situations, 106
empirical status of, 105
empirical support, 107
facilitating factor, 107
focused, 401
implications in various health-care environments, 107
models of function and dysfunction, 104–6
personality disorders (PDs), 547
process of, 106–7
of psychopathology, 105
for schizophrenia, 489–90
self-harm and ICD, 527
for sexual dysfunctions, 455, 457, 467
therapeutic relationship, 106
Cognitive biases, 318
Cognitive concepts, 104
Cognitive disorders, in adults, 582–606
alcohol exposure and, 590
Alzheimer disease, 570, 584, 591
brain insults, 588
cerebrovascular disorders, 592–93
characteristics, 582–83
classification of, 584–85
DSM-IV taxonomy, 584
due to chemicals, 589–90
exposure to industrial chemicals, 590–91
focal, 587–88
head trauma, 588
herpes encephalitis, 589
human immunodeficiency virus (HIV), 589
manifestations of developmental conditions, 582–83
medical and neurological disorders, 584, 588, 591–93
mild cognitive impairment, 592
neuropsychiatric and psychiatric disorders, 583
neuropsychological functions and domains, 585–86
primary progressive dementias, 591–92
prion disease, 589
Cognitive impulsiveness, 522
Cognitive processing therapy (CPT), 175, 382
Cognitive therapy (CT), 332–34
Commission for the Recognition of Specialties and Proficiencies in Professional Psychology (CRSPPP), 161
Committee on Scientific and Professional Ethics (CSPE), 187
Communications, learning disorders in, 562–65
Community health center psychologist life of, 41–43
Community health centers-based psychology training programs, 40
Community Living Centers (CLCs), 176
Community Reinforcement Approach (CRA), 436
Comorbid panic disorder, 302–303
Comorbid personality disorders, 303, 306
Competence, ethic of, 197–99
Competency Assessment Toolkit for Professional Psychology, 151–52
Competency Benchmarks, 151–52
Composite International Diagnostic Interview (CIDI), 235
Comprehensive Handbook of Psychotherapy Integration, 117
Comprehensive System (CS), 78–79
Computerized cognitive- behavioral therapy (CCBT), 629
for anxiety disorders, 634—35
for depression, 632—33
for EST-naive clinicians, 636–37
Concientization, 890
Conditioned reflexes, 25
Conditioning, 16
Conduct disorder, 259
adolescent-onset type, 572
assessment and treatment, 573
biological influences, 573
childhood-onset type, 572
clinical description, 572
epidemiology, 572
etiology, 572–73
familial environmental influences, 573
Confabulation, 694
Confidentiality, 192–94, 230
Confirmation bias, 243
Consensual sadomasochism, 466
Consent. See Informed consent
Consolidated Standards of Reporting Trials (CONSORT) Group, 140
flow diagram, 68, 69f
statement, 140
Constructivist epistemology, 109
Continuing education (CE), 627
Continuous Performance Test, 585
Control-referenced effects, 111
Conversion disorders
demographic characteristics, 347
diagnostic criteria and prevalence, 346
treatment, 347
Coordinated Anxiety Learning and Management (CALM) tool, 636–37, 914
COPE for depression, 632
Coping Cat
youth anxiety protocol, 214
Coping Koala
Australian version, 214
(p. 928) Core maladaptive emotion schemes, 110
Coronary artery bypass graft (CABG), 710
Coronary heart disease (CHD), 709
Corrective emotional experiences (CEE), 102–3
Cortical basal-ganglionic degeneration (CBDG), 598
Corticotrophin-releasing factor (CRF), 416
Council of Chairs of Training Councils (CCTC), 180
Council of Credentialing Organizations in Professional Psychology (CCOPP), 161
Countertransferences, 102
Couple interview, 249–50
Couple therapy, 115, 798–818
behavioral, 800–802
cognitive-behavioral, 802–804
efficacy of, 811–14
emotionally focused (EFCT), 799
emotionally focused (EFT), 806–809
insight-oriented (IOCT), 809–10
rate of marital distress and dissolution, 799
Courts
Association of Family and Conciliation Courts (AFCC), 80
drug courts, defendants in, 668–71
individuals adjudicated incompetent to stand trial (IST), 675–80
Craske, Michelle, 16
Creutzfeldt-Jakob disease (CJD), 584, 589
Crises vs. emergencies, 748–49
Crisis management with naturalistic follow-up (CMNF), 301
Criterion variance, 233
CT (Cognitive therapy), 332–34
Cuento therapy, 890
Cultural formulation, 879
Cultural imperialism, 878
Cultural mirrors, in therapeutic process, 881–82
Culturally competent clinicians, 878
Culturally diverse populations, 877–896
African Americans, 878, 884–85
American Psychological Association guidelines for, 879–80
Asians, 883–85
bicultural effectiveness training (BET), 889
clinical practice, 878–79
Dichos psychotherapy, 889–90
ethnic minority individuals’ discomfort with mental health treatment, 879
ethnic-specific psychological practice, 889–91
evidence-based practice, 881
family constellation treatment, 890
family effectiveness training (FET), 889
historical transference, 888
Japanese, 890
Latinos, 884–85, 890
liberation psychology, 890
Native Americans, 884–85
object-relation model of clinical practice, 879
psychopharmacology, 879
psychopolitical reaction among African Americans, 878
racial and ethnic identity development, 885—86
realities or special needs of linguistic minorities, 889
response from mental health organizations, 879–80
therapeutic communication issues, 888–89
therapeutic encounter of, 878
therapeutic relationship, 884–85
therapists’ feelings and attitudes, 886–87
transference and countertransference, 886–89
worldview, 882–84
Cumulative Index to Nursing and Allied Health Literature (CINHL), 141
Cyclic guanosine monophosphate (cGMP), 459
Cyclothymia, 297, 303
Cyclothymic-anxious-sensitive disposition, 304
Cyproheptadine, 395
Cyproterone acetate, 467
Cystic fibrosis, 907
D-cycloserine (DCS), 912
Data-analytic techniques, 16
DClinPsy degree, 27
Deepening emotional processing, 110
Deescalation, 114
Defense mechanisms, 102
Defense of Marriage Act, 848
Defensive medicine, 186
Deinstitutionalization, 211
Delay discounting, 522
Delirium, 584
(p. 929) Delusional disorder, 264
Dementia, 584
behavior problems associated with, 828
dementia praecox, 24, 480
primary progressive dementias, 591–92
pseudodementia, 696
substance-induced persisting dementia, 584
vascular dementia, 584, 593–94
Dementia praecox, 24, 480
Department of Veterans Affairs (VA), 169–80
The Best Care Anywhere, 173
challenges, 172
community-based outpatient clinics, 174–75
employment, 169, 170, 172t
goals for transforming mental health care, 172
health-care settings, 174–79
as health-care system, 170
history of psychology in, 71
homeless services, 177
integration of mental health and primary care, 175
military sexual trauma (MST), 178
professional organizations, 171
psychogeriatric care, 176–77
psychologists employed, 172t
residential rehabilitation, 177
responsibilities, 170
service provided by psychologists, 179
strategic plans for providing mental health care, 171–73
substance use disorder and dual diagnosis programs, 177
suicide prevention, 178
training program for health professions, 180
treatment for PTSD, 175–76
Depression, 107
helplessness model of, 105
symptoms, 100
Depressive personality disorder (DPD), 263
Depressiveness, 259
Derogatis Interview for Sexual Functioning (DISF/ DISF-SR), 453
Desipramine, 399
Developmental disorders, 558–81
attention-deficit hyperactivity disorder (ADHD), 559–62
communication and related disorders, 565t
conduct disorder, 572–73
expressive language disorders, 565t
intellectual disabilities (ID), 568–70
z
intermittent explosive disorder, 575
learning, 562–65
Oppositional defiant disorder (ODD), 573–74
pervasive, 569
selective mutism, 565t
spectrum of disorders, 558–60
Diagnostic assessment, 114, 256–280
Diagnostic and Statistical Manual of Mental Disorders (DSM), 233
Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III), 258, 905
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
Axis I disorders, 235
hypomania, 304
Mood Disorders Work Group, 263
Personality Disorders Work Group, 263
substance use disorder (SUD) criteria, 413
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), 257
mental retardation in, 260
personality disorder diagnostic categories of, 267–270
schizotypal personality disorder, 264
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V), 256–280
abbreviated version of FFM proposal for, 270f
alcohol abuse Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) and dependence, 261–62
depression, 263–65
dimensional models for, 257–59
discussion, 267–270
intellectual disability, 260–61
internalization and externalization, 259–60
personality disorders, 267–270
Research Planning Work Groups, 257
white papers of Research Planning Work Groups, 257
Diagnostic Interview Schedule (DIS), 228, 234
Diagnostic Interview Schedule for Children (DISC), 234–35
Diagnostic orphans, 262
Dialectical behavior therapy (DBT), 272, 527, 546
Dichos psychotherapy, 889–90
Digit Span Backward, 586
Digit Span forward, 585
Dimensional Assessment of Personality Pathology- Basic Questionnaire (DAPPBQ), 539
Dimensional Obsessive Compulsive Scale (DOCS), 328
(p. 930) Directed masturbation technique, 456
Disorder-specific measures, 237
Disorders of Memory, 25
Disruptive behavior, 264
Dissociation, 365
Dissociative disorders, 366
Dissociative Experiences Scale (DES), 367
Disulfiram (Antabuse), 437
Divalproex, 297
Division 12 Task Force, 136, 212–13
Doctoral clinical psychology programs, 5, 150
Dominant gene, 569
Dominant gene disorder, 569
Down, Langdon, 570
Down syndrome, 570–71
Drug abuse and dependence, 259
Drug courts, defendants in, 668–71
Drug placebo condition, 17
Drunk driving laws, 431
Dual-process models, 422
Dual representation theory (DRT), 373
DUI (drunk driving laws), 431
Dural arteriovenous fistulas, 594
Dusky v. United States, 676
DWI (drunk driving laws), 431
Dynamic sensibility, 100
Dynamic-specific constructs, 103
Dynamic therapies, 101, 103
Dysfunctional Attitudes Scale, 247
Dyspareunia, 456, 462
Dysthymia, 283–84, 366
Early intensive behavioral intervention (EIBI), 567
Early-onset dysthymia, 263–64
Eating disorders, 107, 317, 392–409
not otherwise specified (EDNOS), 401
EBI (evidence-based instruments), 83–93
Echolalia, 568
Ecological Model for Health Promotion, 733
Education and training, in clinical psychology, 150–168
accreditations, 153
advanced credentialing and specialization, 160–61
clinical psychologists as health-service provider, 162–63
Clinical Scientist model, 153–54
competencies, 151–53
credentialing, 158–62
doctoral internship, 154–56
embedding of, 163
emerging trends, 156–58
Examination for Professional Practice in Psychology (EPPP), 161
gender differences, 163–64
global mobility issues, 160
internship match imbalances, 155
licensing laws, 158–59
link with credentialing/licensure systems, 161–62
models, 152–54
practice settings and requirements for licensure, 159–60
Scientist-Practitioner model, 153–54
toolkits, 152
Effectiveness, 15, 212
Effectiveness and Efficiency: Random Reflections on Health Services, 129
Efficacy, 15, 212
Egyptian medicine, 24
Electromyogram (EMG)- biofeedback, 353
Elmore, Diane, 36
EMBASE, 141
Emergencies, risk of harm to self or others. See Behavioral emergency
Emotion-focused individual therapy (EFT), 111
Emotion-related schematic models, 105
Emotion schemes, 108
Emotional processing theory, 105
Emotionally focused couple therapy (EFCT), 799
Emotionally focused couple therapy (EFT), 114–15
approaches to treatment, 808–809
basic concepts, 807
contributions, 807–808
empirical support, 809
Empirically supported treatments (ESTs), 136, 627, 658, 679–80
Empirically validated treatments, 136, 136t
Employment
Department of Veterans Affairs (VA), 169, 170, 172t
schizophrenia, supported employment, 485–86
(p. 931) Endophenotypic latent constructs, 259
Epilepsy, 583, 599–600
Greek tradition, 24
Equivalency testing method, 63
Erectile disorder, 459–60
ERP (Exposure and response prevention), 330–32
Escobar’s abridged somatization, 343
Estimating risk of harm to self or others. See Behavioral emergency
Ethical issues, in clinical psychology, 185–210
American Psychological Association’s approach, 187–89
basic assumptions, 186–87
boundaries, 199–200
Canadian Psychological Association’s approach, 187–90
challenges encountered by APA members, 187
competence, 197–97
confidentiality, privacy, and privileges, 192–94
dilemmas to its members, 189
formal complaints and ethical dilemmas of psychologists, 190–92
incidents that are challenging, 190–91
informed consent, 194–97
national security, 201–02
professional liability suits, issues with, 192
sound ethical decisionmaking, 186–7
standards set by APA members, 188
steps in decision-making, 203–5
Ethnocultural allodynia, 881
Ethnocultural psychotherapy, 891
Evidence-based assessment (EBA), 76–97
clinical instruments commonly used, scientific limitations of, 78–79
clinical relevance, 84–86
clinical utility, 81, 92
conceptualization and evaluation of, 81–83
criteria for rating assessment instruments, 87t-88t, 90t-91t
criteria for rating outcome measures for use in child and adolescent mental health services, 84t
evidence-based instruments (EBI), 83–93
incremental validity, 92
initiatives and criteria, 83–88
integration of data and clinical-decision making, 92–93
modular outcome measurement system, 83
problems and limitations, 78
problems with instrument selection and interpretation, 80–81
psychological EBAs, 91–93
psychometric criteria, 83
psychopathology in youth, criteria for instruments assessing, 90t—91t
relationship with evidence-based practice, 93
Evidence-based Behavioral Practice (EBBP), 133, 902–903
Evidence-based capitulation, 132
Evidence-based health-care practices, 81
Evidence-Based Medicine: How to Practice and Teach EBM, 132
Evidence-based practice (EBP), 7, 128–149
accountability and policies, 129–30
“apply” step, 144
“appraisal” step, 143–44
categories of skills, 134–35
categories of treatment efficacy, 772–73
client preferences, 135
clients’ worldviews and life experiences, 884
cultural adaptation of, 880–81
culturally diverse individuals, 877
effect of racial microaggressions, 881
“empirically validated” psychosocial treatments, 772
growth, 130
health-care quality, 128–29
language used in therapy, 881
lifelong learning, 131–32
metaphors and signs used in therapy, 881
nature of, 772–73
online learning courses, 142
possibly efficacious treatments, 772–73
process, 142–45, 142t
psychologist’s roles, 138–39, 138f
rationale for, 128–29
resources for learning, 142
three-circles model, 132–38
training for, 139–42
transdisciplinary collaboration, 130–31
transdisciplinary model, 134
Evidence-based psychological interventions
APA’s Task Force on Psychological Intervention Guidelines, 212
Center for Evidence Based Practices within Case Western Reserve University, 220
collaboration through research networks, 217
common standard or common architecture, 215–17
Community Development Team Model, 220
cumulative research progress, 215
focus on service quality and cost effectiveness, 212–13
historical background, 211–12
implementation and dissemination strategies, 217–21
(p. 932) Individual-Expert Model, 219
individual-specialization model, 214
IT support, 220
with new second-generation medications, 221
Office of the Surgeon General report, 213
organization and emphasis of research findings, 214—17
representativeness of clinical research, 213
Scientist-Practitioner Model, 219
treatment for alcoholism, 220–21
Evidence-based treatments (EBTs), 82
Exercise interventions, 353–54
Exhibitionism, 465
Experiential theory, 109
Experiential therapy, 111
Experimental neuroses, 25
Exposure and response prevention (ERP), 330–32
Exposure-based therapy, 249
Expressive techniques, 101–2
Externalization constructs, 259
Externalizing disorders, 259
Extinction, 17
Eye movement and desensitization reprocessing (EMDR), 382–83
Eysenck, Hans, 30–31
Face-to-face therapist-client contact, 218
Factitious disorder diagnostic criteria and prevalence, 356
treatment, 356
Familismo, 882
Family-based treatment for youths, 218
Family constellation treatment, 890
Family education, support, and attention (FESA) condition, 54
Family effectiveness training (FET), 889
Family-focused therapy, 300–01
Family psychoeducation, 487–88
Family system therapy, 115
FearFighter, 632
Federal Educational Advocacy Coordinators (FEDAC), 37
Federal mental health-care system, 169–84
emerging federal health-care plans, role of psychology in, 169–84
Medicare Program, 180–82
Veterans Affairs (VA). See Department of Veterans Affairs (VA)
Feedback system, 113
Feighner diagnostic criteria, 343
Female orgasmic disorder, 455–56
Fetal alcohol syndrome (FAS), 418, 569
Fetishism, 464–65
FFT (functional family therapy), 115
Fibromyalgia, 352–57
The Fifteen-Minute Hour, 614
Five-factor model (FFM) of personality disorder, 267–270
Five-Factor Model Rating Form (FFMRF), 268, 269–270f
Flexner Report, 129
Florida Seminole tribe, 24
Fluoxetine, 395–96, 399
Fluoxetine plus olanzapine, 299
Fluvoxamine, 399
Follow-up assessment, 56
Forensic facilities treating IST patients characteristics of incompetent defendants, 676
characteristics of treatment approaches, 678–79
effects of medication on the decisional abilities and incompetency, 676–77
evaluation of treatment component, 681
factors influencing treatment approaches, 679
incompetence to stand trial, 675–80
medication education group, 680
primary role of medication, 680
reality orientation groups, 680
skill-based interventions, 678
standard for determining a defendant’s competency, 676
substance abuse treatment, 680
targeted hybrid treatment, 681
targeted legal services, 680–81
traditional clinical services, 679–80
treatment modalities, 681
Trial Competency Program, 681
use of restraints and seclusion, 680
Fragile X syndrome, 570
Framingham Index, 268
Francis Galton’s theory of intelligence, 27
Frank, Bob, 39
Free from Anxiety, 635
Fregoli syndrome, 694
Freud, Sigmund, 28–30, 98, 99, 101
Freud’s classical psychoanalysis, 98
Fright neurosis, 364
Front-line primary health professionals, 48
Frotteurism, 465
FSAD. See Female sexual arousal disorder (FSAD)
Full manic episode, 297
Full Spectrum Virtual Iraq environment, 639
Functional family therapy (FFT), 115
(p. 933) Functional somatic syndrome, 352–54
cognitive-behavioral therapy, 354–55
cognitive therapy, 354
demographic characteristics, 352
diagnostic criteria and prevalence, 352
exercise interventions, 353–54
operant behavior therapy, 354
relaxation training, 353
treatment, 352–53
Future of clinical psychology, 34–51, 899–919
accreditation systems, 903–904
client outcome assessments, 906–909
clinician profiling, 908
confidentiality provisions, 907
development of treatment manuals, 911–12
diagnosis and assessment, 905–906
dissemination and implementation of psychological treatments, 909–11
DNA sampling, 915
Evidence-based Behavioral Practice (EBBP), 902–903
patient profile with a dimensional classification system, 907f
pharmacological treatments, 912–13
predictions, 900t
psychopathology, 905
psychotherapy, 915–16
training goals, 900–902
treatments, 909–16
use of digital technologies, 913–15
GABA-ergic neurotransmission, 437
Gastroenterology, 25
Gender identity disorder (GID), 468–69
General Health Questionnaire (GHQ), 711
Generalized anxiety disorder (GAD), 237, 259–60, 281–82, 283, 366, 632
Generalized seizures, 600
Gifted children, 27–28
Global positioning system (GPS) watch, 729
Graduate Psychology Education Program (GPE), 155
Graduate Study in Psychology, 155
Gray, Sir Muir, 133
Gray’s biobehavioral emotion theory, 105
Greek tradition of human illness, early, 23–24, 98
Grief, 366
Group therapy, 301–302
Growth tendency, 107
Guided imagery, 353
Guidelines on Multicultural Education, Training, Research, Practice and Organizational Change, 880
Gulf Wars, 369
Hall, Calvin, 187
Hall, G. Stanley, 29
Hallucinations, 695
Halstead-Reitan Neuropsychological Test Battery, 691
Handbook of Psychiatric Measures, 82
Hawaii Psychological Association (HPA), 37–38
Hawaii’s health care initiatives, 40, 44
Head trauma, 588
Health and Behavior Assessment and Intervention (H&B) CPT codes, 181
Health Belief Model, 733
Health care broadened conceptualization of, 46
policy initiatives, in clinical psychology, 164–65
Health Resources and Services Administration (HRSA), 35, 45
Helmholtz, Hermann, 24
Hermeneutic of suspicion, 100
Herpes encephalitis, 589
“Hierarchy of needs,” 108
High-potency tranquilizers, 16
High risk of harm to self or others, behavioral emergencies, 747–70
Hippocrates, 23–25, 98, 905
Hippocratic Oath, 195
Historical transference, 888
History of clinical psychology, 23–33
dementia praecox, 24
hysteria, 26
intelligence quotient (IQ), 27
modern era, 31
psychoanalysis, 30
psychologists, early, 23–31
schizophrenia, 24
Hoarding, 315–18
Hobbs, Nicholas, 188
Hollingworth, Leta, 27–28
Home Based Primary Care (HBPC), 176
Homeless services, 177
Homicide risk, behavioral emergencies, 747–70
Homosexuality. See Sexual-minority population
Hooper Visual Organization Test, 586
Hopelessness, 241
Hot cognitions, 106
(p. 934) Human immunodeficiency virus (HIV), 584, 589
Humanistic/experiential therapies
empirical support, 111—12
models of function and dysfunction, 108—10
neo-humanistic process view, 109
process of, 110–11
strategies and interventions, 110–11
Huntington, George, 598
Huntington disease (HD), 583, 598
Hydrocephalus, 599
normal pressure, 584
Hyperarousal symptoms, 366
Hypersexuality, 466
HyperText Markup Language (HTML), 216
Hypnosis, 29
Hypoactive sexual desire disorder, 458–49
Hypochondriasis, 325–27
defined, 348
diagnostic criteria and prevalence, 348–49
psychosocial treatments, 349
Hypomania, 304
Hypomanic episodes, 297
Hypothalamic-pituitary-adrenocortical (HPA) axis, 416, 714, 906
mobilization, 377
Hypothyroidism, 584
Hysteria, 26
“I Ola Lahui” Rural Hawaii Behavioral Health Program, 40, 44
I-Thou dialogue, 109
Ictal events, 600
Idiopathic epilepsy, 600
Idiosyncratic negative cognitive schemas, 104
Illness anxiety disorder, 325–27
Illusory correlation, 243
Imipramine, 298
Imminent risk of harm to self or others, 747–70
Implied question, 244
Impulse-control disorders (ICDs), 511–536
assessment, 526
behavioral inhibition, 522
characteristics, 513t
compulsions and addiction, 522
conceptualizing, 520–23
essential features, 511
genetic factors, 523
harm to others, 518–20
neurobiological factors, 523–24
nonsuicidal self-injurious thoughts (NSSI) and behaviors, 515
pharmacological treatment strategies, 527–28
prevention programs, 528–29
psychological factors, 525
psychological treatment strategies, 527
social and developmental factors, 524–25
spectrum, 521
treatment of, 527–28
In-session markers, 111
In-the-moment embodied “goings-on,” 108
In-therapy experiencing, 107
Incompetent to stand trial (IST). See Forensic facilities treating IST patients
Individualized case conceptualization, 106
InfoPOEMS, 131
Information variance, 233
Informed consent, 230
in cognitive psychology, 196
as a continuing process, 197
forms for, 196–77
helpful information, 195
legal cases, 195
patient competence, 195
patient’s decision-making process, 196
Inherent organismic tendency, 108
Inhibition, 259
Insight-oriented couple therapy (IOCT), 799, 809–10
approaches to treatment, 810–11
basic concepts, 809–810
contributions, 810
empirical support, 811
proximal vs. distal factors, 810
Insight-oriented marital therapy, 115
Integrated clinical settings, 5, 8–10
Integrated Psychotherapy Consortium (IPC), 215
Integrative behavioral couple therapy (IBCT), 115, 804, 806
Integrative cognitive treatment (ICT), 119
Integrative movements in psychotherapy, 116–20
Intellectual disabilities (ID), 261, 568–72
assessment, 570–71
clinical description and epidemiology, 568
etiology, 569–70
treatment, 570–71
Intelligence, 260
Intelligence quotient (IQ), 27, 80–81, 260–61, 562–66, 583
“Intelligence test” for children, 27
Interactive Cognitive Subsystems (ICS) theory, 105
Interagency collaboration, 218
INTERHEART study, 710
Intermittent explosive disorder, 574
Intermittent explosive disorder (IED)
associated features, 520
defining feature and subtypes, 519
onset and course, 520
prevalence, 520
Internal tacit experiencing, 108
Internalization constructs, 259
Internalized homophobia, 849, 850
(p. 935) Internalizing adaptive objects, 100
Internalizing disorders, 259
International Classification of Diseases (ICD), 233
ICD-9, 397
ICD-10, 264
International Personality Disorder Examination (IPDE), 237, 240
Internet, as anonymous forum for paraphilias, 463
Interpersonal and social rhythm therapy, 302
Interpersonal psychotherapy modified for depressed adolescents (IPT-A), 55
Interview. See Clinical interview
Interviewer bias, 242–43
Intra-ethnocultural countertransferential manifestations, 887
Intra-ethnocultural transferential reactions, 886–87
Intracranial radiation, 584
Intramural Research Program of National Institute of Mental Health (NIMH), 3
“I Ola Lahui” Rural Hawaii Behavioral Health Program, 40, 44
Iraq, Full Spectrum Virtual Iraq environment, 639
Irritable bowel syndrome (IBS), 352, 355
Ischemic stroke, 593
IST (incompetent to stand trial). See Forensic
facilities treating IST patients
Item response theory (IRT), 262
Jackson v. Indiana, 676
Jaffee v. Redmond, 193
James, William, 24
Janet, Pierre, 26
Johnson, Lyndon, 35
Juvenile placement and forensic hospitalization, 657–87
approaches to remove criminogenic needs, 661–63
cognitive-behavioral treatment model, 663–64
conducting of research, 660–61
defendants in drug courts, 668–71
defendants in mental health courts, 671–75
empirically supported treatments, 658, 660–65
family involvement, 664
individuals adjudicated incompetent to stand trial (IST), 675–80
length of time juvenile offenders, 664–65
modification of treatments, 665–66
multifaceted and structured programming, 663
residential placement, 658
residential settings, 658–59
Kaufman Assessment Battery for Children-Second Edition, 571
Kirschner, Neil, 35
Kleptomania, 317
associated features, 519
defining feature and subtypes, 519
onset and course, 519
prevalence, 519
Klonopin, 16
Kraepelin, 297
Kroenke’s multisomatoform disorder, 343
K statistic, 283
La operación, 878
Lamotrigine, 297—98
Last observation carried forward (LOCF), 62
Later life, mental health problem interventions, 819–45
alcohol and drug misuse, 825–27
anxiety disorders, 825
behavior problems associated with dementia, 828
caregiver stress, 828–29
depression, 824–25
diversity among older adults, 831–33
empirical support, 823–24
future directions in geropsychology, 835–36
general assessment issues, 820–21
general intervention issues, 821–23
insomnia, 827–28
marital and family therapy, 836–37
post-traumatic stress reactions, 836
prolonged grief, 829–30, 830t
Learning disorders, 562–65
assessment and treatment, 564–65
clinical description, 562
etiology, 563–64
prevalence, 562
Learning maladaptive behaviors, 104
Learning theory traditions, 104
Lectures on Conditioned Reflexes, 25
Lesch-Nyhan syndrome, 570
Letter-Number Sequencing Test, 586
Leukoencephalopathy, 595
Leuprolide, 467
Leuteinizing hormone-releasing hormone (LHRH) agonists, 467
(p. 936) Lewis, Aubrey, 30
Lewy body disease (LBD), 597
Lexical studies, 267
Like no-treatment conditions, 54
Lithium, 297–98
“Local coverage determinations” (LCDs), 181
Louisiana State Board of Examiners of Psychologists, 38
Lower-level information processing, 700
Lupus, 601
MacArthur Foundation, 215
Major depression, 259
continuum of, 265–66
subthreshold, 266
Major depressive disorder (MDD), 260, 281–82, 696, 701–702, 905–906
Male libido, 458
Male orgasmic disorder, 461–62
Manic-depressive disorder, 24
Marriage. See Couple therapy
Masochism, 465–66
Masters and Johnson’s sex therapy program, 455
Masturbation, 456
Mathematics, learning disorders in, 562–65
Maudsley family therapy, 394
McGuire, Margaret, 26
Medicaid, 41, 180, 212
Medical and neurological disorders, 584–85
Medical apartheid, 878
Medically unexplained physical symptoms (MUPS), 339
Medicare, 180–82
Medicare Improvements for Patients and Providers Act (2008), 182
Medicare Prescription Drug Improvement and Modernization Act (2003), 182
Medicare Program, 180–82
“Medigap” insurance, 180
MEDLINE, 141
Medroxyprogesterone acetate, 467
Mental health courts, 671–75
functions, 671–72
research findings, 672–73
Mental Health Intensive Care Management (MHICM), 174
Mental health issues, 24
Mental health policy. See Policy initiatives affecting psychology
Mental Illness Research Education and Clinical Centers (MIRECCs), 179
Mental retardation. See Intellectual disabilities (ID)
Mental retardation in DSM-IV- TR, 260
Mentalization, 102
Meta-analytic procedures, 66–67
Microcephaly, 261
Military sexual trauma (MST), 178
Mind-Body Interactions, 215
Mini-depressions, 305
Mini-International Neuropsychiatric Interview (MINI), 236–38, 326
Minimum legal drinking age (MLDA), 420
Minnesota Multiphasic Personality Inventory-2 (MMPI-2), 81, 86, 237
Minor depressive disorder, 266
Minors. See Children
Mixed anxiety-depressive disorder, 257
Mobile technologies in health care
cellular coverage, 641
evolution, 641
increasing physical activity, 642
lifestyle and health promotion interventions, 645
medication compliances, 642
monitoring of blood alcohol levels, 642
obesity weight loss interventions, 644–45
in promoting sexual health, 641
providing dialectical behavior therapy (DBT) skills, 642, 645–46
SEXINFO, 645
short-message service (SMS), 642
smoking cessation, 642–43
TXT Quizzes, 643
video and audio messages, 645–46
Modern treatment deliveries, 626–56
Modules, 216
Monoamine oxidase inhibitor (MAO-I) pharmacology, 305
Monotherapy, 298
Montreal Heart Attack Readjustment Trial (M-HART), 711
Mood and Anxiety Symptoms Questionnaire, 247
Mood disorders, 259
Mood intolerance, 398
Mood stabilizers, 297–98, 528, 548
MoodGYM, 631–32
Morgan-Russell criteria, 396
Morita therapy, 890
Mosaicism, 261
Mowrer’s two-factor model of fear, 319
MST Services, Inc., 218
(p. 937) Multidimensional family therapy (MDFT), 115
Multimodal Treatment of Attention-Deficit Hyperactivity Disorder (MTA), 562
Multiple function, 100
Multiple interacting selforganizations, 109
Multiple personality disorder, 26
Multiple sclerosis (MS), 57, 600
N-methyl-D-aspartic acid (NMDA), 437, 912
Naikan therapy, 890
Naltrexone, 220, 395, 437
National Center for Posttraumatic Stress Disorder (NCPTSD), 180
National Child Traumatic Stress Network (NCTSN), 215, 909
National Comorbidity Survey Replication (NCS-R), 368
National Council of Schools and Programs of Professional Psychology (NCSPP), 151
National Guidelines Clearinghouse, 129
National Institute for Health and Clinical Excellence (NICE), 398
National Institute of Alcohol Abuse and Alcoholism (NIAAA), 413
National Institute of Mental Health (NIMH), 30, 211, 257, 915
Treatment of Depression Collaborative Research Program, 31
National Institutes of Health (NIH) Roadmap, 130
National Mental Health Act (1946), 211
National Mental Health Advisory Council, 211
National Register, 159, 160
National security efforts and clinical psychology, 201–02
National Vietnam Veterans Readjustment Study (NVVRS), 369
Native Hawaiian Health Care System clinics (NHHCS), 44
Negative affect, 285
Negotiating Consent in Psychotherapy, 197
NEO Personality Inventory- Revised (NEO PI-R), 267, 545
Network therapy, 890
Neuropsychiatric disorders, 583–84
Neuropsychological functions and domains
attention, 585
executive function, 585–86
fine manual motor skills, 586
general intellectual function/ academic skills, 586
language skills, 586
learning and memory, 586
procedural memory, 586
visuospatial processing, 586
working memory, 586
Neuroscience, 24
Neuroticism, 267
Neuroticism/behavioral inhibition (N/BI), 906
Neurovegetative symptoms, 241
New York Suffrage Party, 28
Nicotine replacement therapy (NRT), 739
NIH Office of Behavioral and Social Science Research (OBSSR), 133
No-treatment control condition, 53–54
Nonsuicidal self-injurious thoughts (NSSI) and behaviors, 515
in adolescents, 515
in adults, 515
associated features, 516
defining features and subtypes, 515
onset and course, 516
prevalence, 515
“Normal” dynamic therapy protocol, 103
Normal-pressure hydrocephalus (NPH), 599
Nortriptyline, 395
Nosology, 281
Not otherwise specified (NOS) disorders, 257, 262, 281, 905
Nuremberg ethic, 188, 203, 878
Oath Betrayed: America’s Torture Doctors, 203
Obesity. See Eating disorders
Object relational approach, 100
Obsessive-compulsive disorder (OCD), 26, 259, 264, 281–83, 286, 313–338, 366, 522, 702, 906
assessment of, 326–28
avoidance strategies, 329
body dysmorphic disorder (BDD), 317, 319, 322
clinical interview, 326–27
cognitive features, 329
(p. 938) cognitive specificity models, 319
cognitive therapy, 332—34
common behavioral rituals, 314
common obsessions, 314—15t
compulsive rituals, 329
conceptual models, 324
definition of, 314—15
empirical status, 322
exposure and response prevention, 319, 330—32
family history, 318
functionally related rituals, 315
general cognitive deficits model, 319–320
hoarding, 315–18
hypochondriasis, 325–27
mental rituals, 314
models of psychopathology, 319
neurobiology of, 317
obsessive-compulsive spectrum disorders (OCSDs), 316t
patterns of comorbidity, 317
presentation of, 313
repetitive behavior, 316
self-monitoring, 329
self reported symptoms, 327, 328
situational triggers, 328
spectrum, 315–16
treatment approaches, 329–32
treatment responses, 318
unwanted thoughts and urges, 313
Office of Juvenile Justice and Delinquency Prevention (OJJDP) Model Programs, 658
Olanzapine (Zyprexa), 297
plus fluoxetine, 298
Olmstead v. U.S., 193
Open questions, 244
La operación, 878
Operant behavior therapy, 354
Operant conditioning, 733
Ophthalmology, 25
Opioid antagonists, 528
Oppositional defiant disorder (ODD), 573–74
Organismic valuing process, 108
Orgasmic disorders, 455–56, 461–62
Outcome-Questionnaire-45 (OQ-45), 92
Over-controlled behaviors, 259
Over-determination, concept of, 100
Pain disorder, 348
sexual pain disorders, 456–58, 462
Panic Control Treatment Online Training (PCT OLT), 913
Panic control treatment (PCT), 17
Panic disorder, 259
with agoraphobia (PDA), 281
Papyrus, Ebers, 24
Papyrus, Edwin Smith, 24
Paranoid personality disorder, 264
Paraphilic disorders courtship disorders, 465
fetishism, 464
hypersexuality, 466
pedophilia, 463
sexual masochism, 465–66
sexual sadism, 465–66
transvestic fetishism, 464–65
treatment of, 466–67
Parkinson disease, 595–96
Parkinsonism, 595–96
Paroxetine, 298
Partial seizures, 600
Pathologic gambling, 317
associated features, 518
defining features and subtypes, 517
onset and course, 518
prevalence, 517–18
Patient variance, 234
Paul Wellstone and Pete Domenici Mental Health Parity, 37
Pavlov, Ivan, 24–25
Paxil, 16
PDE-5 inhibitors, 459
Pedophilia, 463
PEDRO, 141
Penile plethysmography, 463
Performance IQ (PIQ), 691
Person-centered view, 108
Personal Information Protection and Electronic Documents Act (PIPEDA), 193
Personality disorders (PDs), 107, 237, 257, 537–557, 696
assessment, 543–45
Axis I and Axis II disorder model, 540–41, 548–49
biological and genetic basis of, 541
borderline, 547
comorbidity, 540, 548–49
conceptual overview of, 538–39
diagnostic categories, of DSM-IV-TR, 267–270
dimensional conceptualizations, 539–40
in DSM, 537
etiology and development, 541–343
Five Factor Model (FFM), 539
intensive, short-term dynamic psychotherapy (ISTDP), 546–47
longitudinal course and relational impairment, 542
pharmacological agents, 548
psychosocial and cultural factors, 541
treatment, 546–48
Personality disorders (PDs)
schizotypal personality disorder, 481
Persuasion and Healing, 116
Pervasive developmental disorders
Asperger disorder, 565–66
assessment, 567–68
Autism spectrum disorder (ASD), 565–68
not otherwise specified (PDD-NOS), 565
treatment, 567–68
Peyronie disease, 462
Phallometry, 463
Phenylketonuria (PKU), 569
Philadelphia preparatory school, 26
Phobias, 259
Phosphodiesterases (PDEs), 459
(p. 939) Physical activity
assessment, 728–29
benefits, 730
efficacy of interventions, 727–28
enjoyment in, 731
face-to-face interventions, 727
as habit, 731–32
health benefits, 726
at individual level, 728–29
internet-based intervention, 728
moderate- and vigorous- intensity, 725–26
monitoring intensity, 729
prescription, 729
recommendations, 725–26
safety issues, 729–30
self-efficacy for, 731
self-monitoring and goal setting, 730
social cognitive theory (SCT), 726–27
social support for, 731
telephone and print interventions, 728
theoretical models, 726–27
transtheoretical model (TTM), 727
for treating metabolic syndrome, 726
Pick disease, 584
PICO language, 141
Pimozide, 395
Pinel, Philippe, 25
Policy initiatives affecting psychology, 34–51, 211–223
clinical psychology’s long-term perspective, 46–48
mental health parity legislation, 37
Mental Health Policy Research, 215
partnerships and psychological service provision in community health centers, 39–42
personal relationships, 44–46
prescriptive authority (RxP) agenda, 37–39
by professional advocacy organizations, 34–35
public policy process, 35–37
Polygraph testing, 463
Positive affect, 285
Post-traumatic stress disorder (PTSD), 42, 259, 281, 285, 480, 583, 628, 703, 906
across globe, 369–70
among refugees, 370–71
assessment methods and prediction, 381–82
attention and, 375
avoidance and numbing symptoms, 367
Barlow’s model of anxiety and panic, 371–72
betrayal trauma theory (BTT), 374–75
cognitive model, 372–73
cognitive processing therapy, 382
in developed countries, 370
DSM considerations, 367–69
dual representation theory (DRT) of, 373
explicit memory deficits and, 376
exposure-response distinction, 367
flashback episodes, 365
following disaster and terrorism, 371
Holocaust survivors, 376
in later life, 836
notion of a trauma condition, 365
prevalence issues, 368–69
psychobiological abnormalities, 377–78
psychophysiological symptoms, 376–77
risk and resiliency trajectories, 379–80
Schematic, Propositional, Analogue, and Associative Representational Systems (SPAARS) model, 374
trauma spectrum, 366–67
treatment for, 175–76, 382–83
Postpsychotic depressive disorder of schizophrenia, 257
Posttraumatic Adjustment Scale, 381
Practice Guideline for the Psychiatric Evaluation of Adults, 82
Prader-Willi syndrome, 261
Predictions, in clinical psychology by area, 900t
Premature ejaculation (PE), 460–61
Prenatal alcohol exposure, 418
Present-present bias, 243
Presidential Task Force on Psychological Ethics and National Security, 201
President’s Commission on Mental Health, 212
Primary care interventions, 609–625
appointment times, 610–12
average primary care visit, 614
common complaints, 617–18
de facto mental health system in United States, 613
detection and treatment of depression and substance abuse, 622
directive of care, 617
distinction between physical and mental health problems, 609–10
federally designated medical specialties in, 613
issues with physicians, 610
medical and psychological conditions of patients, 615
pain complaints, 613
patient’s expectation of treatment, 617
patient’s health attitude, 615–16
patient’s reaction to psychologist, 614
patient’s social network, 612
patients with psychological disorders, 613
primary care clinical psychologist’s work life, 610–12
(p. 940) psychological treatment skills, 618–19
referrals, issues with, 610
therapeutic relations, 610, 620–21
in United States, 609
Primary Care Posttraumatic Stress Disorder Screen (PC- PTSD), 381
Primary movements in psychotherapy, 98–127
Principles of Psychology, The, 24
Prion disease, 589
Privacy Act of 1982, 193
Privilege, defined, 193
Probe format chart, 234
Process experiential emotion focused (PE/EFT) therapy, 112
Progressive supranuclear palsy (PSP), 597–98
Project MATCH Research, 435
Projective questions, 244
Prolonged exposure (PE) therapy, 175, 382
Protective factors, 241
Provoked vestibulodynia (PVD), 457
Prozac, 16
Pseudodementia, 696
Psychasthenia, 26
Psychiatric disorders, 583–84
Psycho-educator, 110
Psychoanalysis, 28, 30
Psychodynamic therapy, 548
complementary levels of discourse/communication, 101
important schools, 99–100
models of function and dysfunction, 100–101
psychodynamic psychotherapy, process of, 101–4
targets of dynamic psychotherapy, 101
treatment guides/manuals for specific disorders, 104t
Psychoeducation, 291, 302
Psychogeriatric care, 176–77
Psychological Clinic, The, 26
Psychological interventions, 709–24
barriers to adherence, 718–19
barriers to psychological/ behavioral interventions, 718–19
cancer, 712–15
chronic obstructive pulmonary disease, 715
coronary heart disease, 709–12
diabetes, 715
encouraging physical activity, 716–17
Multiple Family Group (MFG) intervention, 718
Multisite Cardiac Lifestyle Intervention Program, 717
myocardial infarction (MI) patients, 709
relaxation training programs, 711
smoking cessation, 716
stress management programs, 712
Psychopathological processes, 16
Psychopathology, 104, 281
dimensional classification of, 260
in object relational terms, 100–101
Psychosocial Rehabilitation and Recovery Center (PRRC) program, 175
Psychotherapist-client privileges, 193
Psychotherapy, 302
cognitive-behavioral therapy (CBT), 104–7
humanistic/experiential therapies, 108–12
integration, 116–20
psychodynamic approach, 100–104
research around individual, 15–16
systemic approaches, 112–16
Psychotherapy by Reciprocal Inhibition, 31
Psychotherapy integration, 116–20
PsycINFO, 141
PTSD
Statistical Prediction Instrument (PSPI), 382
Public health settings, behavioral interventions in, 725–46
for overweight and obesity, 732–33
physical activity, 725–26
smoking cessation, 737–43
Public policy
Public Policy Advocacy Network (PPAN), 37
Pussin, Jean-Baptiste, 25
Pyromania, 316, 317, 518, 519
associated features, 519
defining features and subtypes, 518
onset and course, 519
prevalence, 518
Quality Chasm framework, 48
QUEST, 41
Quetiapine (Seroquel), 297–298
QuitNet, 647
Racial and ethnic identity development, 885–86
Randomized clinical trials (RCTs), 54, 68, 129, 709, 908
Reading, learning disorders in, 562–65
“Real” relationship, 102
Recessive gene, 569
Recurrent Coronary Prevention Project (RCPP), 709
Reduplicative paramnesia, 694
Reflective consciousness, 107
Refranes, 889
Reik, Theodore, 29
(p. 941) Relationship distress. See Couple therapy
Relaxation training, 353
Reliable Change Index (RCI), 63–64
Research methods, in clinical psychology, 52–75
analysis of attrition and its predictors, 61–62
attention-placebo controls, 54–55
clinical significance, 63
coding of results, 68
communicating of study findings, 68
comparability of conditions, 57
conclusions on clinical and statistical significance, 64
CONSORT flow diagram, 68, 69f
data analysis, 61–68
defining of independent variable, 58–59
dependent variables, assessment of, 60–61
effect sizes and inverse variance weights across studies, 67
manual-based treatments, 58
mediator-to-outcome path, 65
mediator variable, 64–65
meta-analytic procedures, 66–67
moderator variable, 65–66
normative comparisons, 63
peer-review process, 69
persuasiveness of outcomes, 62–63
post-hoc probing approach, 65
prerequisite conditions for testing mediational effects, 65
publishing of outcomes of a study, 69
random assignment of participants, 55
Reliable Change Index (RCI), 63–64
sampling issues, 59–60
selection of control conditions, 52–55
setting requirements, 60
statistical tests, 63
testing for moderation of treatment effects, 65
treatment-by-age interaction effect, 65
treatment fidelity checks, 58–59
treatment-to-mediator path, 65
treatment-to-outcome effect, 66
use of a standard treatment, 55
Residential rehabilitation, 177
Resnick, Bob, 38
Resource for Advancing Children’s Health Institute’s (REACH), 215
Retrograde amnesia, 25
Rett disorder, 565
Ribot, Theodule, 25–26
Ribot’s Law, 25
Richmond, Marilyn, 37
Risk of harm to self or others, behavioral emergency, 747–70
Risperidone (Risperdal), 297
Rorschach inkblot test, 78
Sadism, 465–66
Safety Planning for Veterans, 178
Salpetriere Hospital, 25
Same-sex attraction. See Sexual- minority population
Saving or losing “face,” concept of, 883
Schedule for Affective Disorders and Schizophrenia-Lifetime Anxiety Version (SADS- LA), 281
Schedule for Nonadaptive and Adaptive Personality (SNAP), 539, 540, 545
Schizoaffective disorder, 257
Schizoid, 264
Schizophrenia, 3, 24, 85, 107, 241, 257, 476–510, 704
assertive community treatment, 488–89
cognitive-behavioral therapy, 489–90
cognitive impairment, 479
cognitive remediation, 490–91
comorbidity factors, 479–80
cultural factors, 478
depression in patients with, 479
diagnostic systems and history, 480–81
disorganization symptoms, 479
environmental factors, 482
ethnicity, 478
family psychoeducation, 487–88
functional impairment, 479
gender differences, 478
genetic factors, 482
illness self-management training, 493–95
integrated treatment programs, 492–93
negative symptoms, 479
onset and course, 477
parallel treatment, 492
peer support, 495–96
pharmacological treatment, 484–85
prevalence, 477
psychosocial skill training, 485–97
psychotic symptoms, 479
recovery paradigm, 483
risk factors, 478
risk of violence, 479
schizoaffective disorder, 481
schizophrenia-spectrum disorders, 481
schizotypal personality disorder, 481
self-care and community survival skills, impairment of, 479
self-management training, 493–95
sequential treatment, 492
social skills training, 486–87
Stress-Vulnerability Model, 483
supported employment, 485–86
supported housing, 496
systems of care, 484
token economy, 495
trauma-related problems, 496–97
treatment, 483–97
types of symptoms, 478–79
(p. 942) Schizophrenia-spectrum disorders, 481
Schizophrenia spectrum disorders, 698
Schizophreniform disorder, 481
Schizotypal personality disorder, 481, 698
Schloendorff v. Society of New York Hospital, 195
Schools of Psychotherapy, 98–127
Science, technology, engineering, and math (STEM) initiatives, 35
Scientific thinking, 4
Scientist-Practitioner Model of training, 3
Seguin, Edouard, 26
Seizure disorder, 583
Seizures, 24
Selective serotonin reuptake inhibitors (SSRIs), 16, 400, 454, 527, 548
Self-harm, 511–36, 747–70
assessment, 526
characteristics, 513t
conceptualizing, 520–23
essential feature of, 512
genetic factors, 523
neurobiological factors, 523–24
pharmacological treatment strategies, 527–28
prevention programs, 528–29
psychological factors, 525
psychological treatment strategies, 527
social and developmental factors, 524–25
suicidal behaviors, 512–15
treatment of, 527–28
Self-help Behavioral Weight Loss (BWL), 405
Self/life-narratives, 102
Self-report personality questionnaires, 237
Sensate focus, 455
Seroquel (Quetiapine), 297, 298
Serotonin transporter (5-HTT), 417
Sex and gender disorders, 452–475
biological basis of sex and gender, 468
gender identity disorder (GID), 468–69
Sexual aversion disorder, 455
Sexual desire, 458
Sexual dysfunctions in men, 458–462
dyspareunia, 462
erectile disorder, 459–60
hypoactive sexual desire disorder, 458–59
male orgasmic disorder, 461–62
premature ejaculation (PE), 460–61
Sexual dysfunctions in women, 453–458
female orgasmic disorder, 455–56
sexual aversion disorder, 455
sexual desire and arousal disorders, 453–55
sexual pain disorders, 456–58
Sexual masochism, 465–66
Sexual-minority population, 846–76
African American communities, 854
anxiety, depression, or general mental health, 849, 856–57
bisexual subtypes, 859–60
case of multiple identity development, 863–64
defining, 847–48
depression, 849
disclosure of one’s sexuality, 852–53
family ties, 852
heterosexual siblings, behavior of, 849
identity development and transition, 861–63
individual with same-sex attractions, 847–48
interpersonal interactions and broad-based cultural norms, impacts, 848
lesbian and gay individuals, 846
lesbian-gay-bisexual identification, 847
lesbian-gay community, 858–59
mental health problems, 848–50, 856–58
negative social attitudes toward same-sex sexuality, 849
notions of homosexuals, 848
prejudice or discrimination against, 848
psychosocial challenges, 855–56
rejection of all identities, 864–65
self-injurious behavior, 849
sexual-minority status, 860–61
social attitudes toward same-sex sexuality, impacts, 849
social support resources and institutional protections for, 849
South Asian families, 854
stress and mental health, 848–50
substance use, 857
subtypes, 858–60
suicidality, 851–52, 857–58
unique issues, 853–54
women’s sexual identity, 865–66
youth, 850–52
Sexual pain disorders, 456–58, 462
Sexual sadism, 465–66
Shakow, David, 3, 30, 899
aspects of psychological assessment, 10–12
clinical psychology programs, placement of, 6
clinical training, 4–10
delineation of clinical research and practice, 6
divisions in APA, 7
evidence-based practice (EBP), 7
integrated clinical settings, 8–10
panic disorder, treatment of, 16–18
(p. 943) “phenomenal” growth in clinical psychology, views, 4
Practitioner-Scholar model, 8–9
psychotherapy, practice of, 12–16
research efforts in clinical programs, 5–6
Scientist-Practitioner model, 7–8
standards for committees, 6
standards for evaluating competence, 10
treatment manuals and clinical practice guidelines, 15
vision for future of clinical psychology, 7
Shy, 259
SIGN rating systems, 141
Similarities Test, 586
Simon, Theodore, 27
Single-interview method, 282
Situationally accessible memories (SAMs), 373–74
Slip cards, 742
Smoking cessation
basic strategies, 740–41
cognitive behavior therapy, 738, 740
computer-based interventions, 739
group-level therapies, 739–40
health consequences of smoking, 737
individual-level therapies, 739–40
managing withdrawal symptoms, 742
multiple approaches, 742
negative self-talk, 742
nicotine replacement therapy (NRT), 739
problem-solving skills, 743
process of quitting, 741
relapse prevention strategies, 739, 741
self-monitoring, 741
smoking and morbidity, 737–38
smoking as learned addiction, 742
smoking prevalence, 737
social support, 741
stress management, 742
theoretical models, 738
time management, 742–43
using slip cards, 742
Social construction therapies, 114
Social network services, 647–48
Social norms marketing, 432
Social phobia (SOC), 281, 285–86, 366, 628, 906
Social Security Act, 180
Society for Research in Child Development (SRCD), 36
Society for the Exploration of Psychotherapy Integration (SEPI), 117
Sociocentric worldview, 882–84
concept of saving or losing “face,” 883
contextualism, 883–84
familismo, 882
prevention of the threat to face, 883
transpersonality, 883
Socratic questioning, 106, 382
Somatization, 339
Somatoform disorders, 257, 339–363
background, 339–40
demographic characteristic, 344–45
diagnostic criteria and prevalence, 343–45
models of, 342–43
psychodynamic roots, 340
sociocultural and conceptual issues, 341–43
treatment, 345
Spearman, Charles, 27
Standardized self-report measures, of dysfunctional beliefs, 247
Standards for Educational and Psychological Testing, 83
Stanford-Binet-Fourth Edition, 570
Stanford Binet test, 27
K statistic, 283
Stem-and-leaf plot, 67
Stratified blocking, 57
Strickland, Ted, 36
Stroke, cognitive effects of, 593
Stroop Task, 586
Structured Clinical Interview for DSM-III-R Axis I, 282
Structured Clinical Interview for DSM-IV (SCID-IV), 230, 235–36
Structured Interview for DSM-IV Personality Disorders (SIDP-IV), 237, 240, 544
Subacute spongiform encephalopathy (SSE), 589
Substance Abuse and Mental Health Services Administration (SAMHSA), 144, 165, 212, 647, 909
Substance-induced persisting amnestic disorder, 584
Substance-induced persisting dementia, 584
Suicide risk
behavioral emergencies, 747–70
clinical interview, 240–42
Systemic approaches to psychotherapy, 112–16
Systemic lupus erythematosus, 601
Tacit experiencing, internal, 108
Tailored Internet group, 728
“Talking cure,” 98
Taxometrics, 265
Technical eclecticism, 118
(p. 944) Technology-based treatments, in EST
advantages, 629
computerized cognitive- behavioral therapy (CCBT), 629–30
leveraging to link research and practice, 627–28
mobile technologies, 641
self-help options, 629–30
social network services, 647–48
using computers, 629
virtual reality (VR), 637–38
Telephone-based interventions, 711
Tell Me a Story (TEMAS), 890
Temporal lobe epilepsy (TLE), 600
Terman, Lewis M., 28
Test of Memory Malingering, 80
Testimonio, 890
Thematic Apperception Test (TAT), 79
Theoretical integration, 118
Therapeutic actions, 102–3
Therapeutic alliance, 102
Therapeutic relationship, among culturally diverse people, 884–85
Thorndike, Edward L., 28
“Thrownness,” 101
Tolman, Edward, 908
Topiramate, 399, 437
Transdiagnostic treatment approaches, 291–92
Transdisciplinary collaboration, 130–31
Transdisciplinary EBP model, 133
Transference phenomenon, 29, 102
Transient ischemic attacks, 593
Transpersonality, 883
Transvestic fetishism, 464–65
Trauma and trauma-related disorders, 364–91
life stress, 364
neurosis, 364
personality disorders, 366
phobias, 366
trauma sequelae, descriptions of, 364
traumatic brain injury (TBI), 175
Traumatic brain injury (TBI), 175, 583, 588
Trazodone, 399
Treatment as usual (TAU), 548
with manual-guided therapy, 789
Treatment deliveries, technology in, 626–56
Treatment fidelity, 140
Trichotillomania, 317
associated features, 517
defining features and subtypes, 516
hair-pulling in, 516
prevalence, 517
Tripler Army Medical Center (TAMC), 40
Trisomy 21, 261, 569
Tuberous sclerosis, 261, 569
Twelve-Step Facilitation, 435, 436
Twenty-Minute Hour, The, 614
Twitter, 647–48
Type A behavior pattern (TABP), 709
Uniform Mental Health Services Handbook, 178
Uniformed Services University of the Health Sciences (USUHS), 38
Unipolar depression, 286, 304–5
United Kingdom’s National Institute of Clinical Excellence (NICE), 129
U.S. Preventive Services Task Force (USPTF), 130
U.S health-care system, 165
Vaginismus, 456
Vail model programs, 8
Vascular cognitive impairment (VCI), 594
Vascular dementia, 584, 593–94
Verbal IQ (VIQ), 691
Verbally accessible memories (VAMs), 373–74
Vergüenza, 883
Vicissitudes, of human psychopathology, 100
Vietnam Era Veterans (VEVs), 369
Vietnam Theater Veterans (VTVs), 369
Vineland Adaptive Behavior Scales, 571
Violence, risk of harm to self or others, 747–70
schizophrenia, 479
Violence Risk Appraisal Guide, 80
Virtual reality (VR)
Full Spectrum Virtual Iraq environment, 639
in pain reduction, 639–40
role of presence in, 638
in training professionals, 640–41
in treatment of anxiety disorders, 637–38
in treatment of burn patients, 640
Visual Span forward, 585
Vitamin B12
deficiency, 584
Vivitrol, 437
Von Recklinghausen disease, 261
Voyeurism, 465
Vulvar vestibulitis syndrome, 457
Waianae Coast Comprehensive Health Center, 40
Waimanalo Health Center (WHC), Hawaii, 42
Waitlist conditions, 54
Wallin, J. E. Wallace, 27
Washington v. Harper, 677
Wechsler Intelligence Scale for Children-Fourth Edition, 570
(p. 945) Wechsler intelligence scales, 80
Wechsler Memory Scale Visual Reproduction, 586
Wechsler Preschool and Primary Scale of Intelligence-Third Edition, 570
Wechsler scales, 691
Weight loss
behavioral group-based interventions, 734
communities and families, role of, 736
community-based interventions, 735–36
community-level organizations, role of, 735
diet control, 734
efficacy of interventions, 734–35
health-care industry, role of, 736
internet-based interventions, 734
maintenance, 733–34
media, role of, 737
overweight and obesity, health consequences, 732
theoretical model, 733
Welch v. American Psychoanalytic Association, 29
White matter disease/white matter lesions, 594
Wide Range Achievement Test Reading, 586
Wild Boy of Aveyron, 26
Wisconsin Card Sorting Test, 586
Witmer, Lightner, 4, 26–27
World Health Organization (WHO), 233, 241
World Professional Association for Transgender Health (WPATH), 469–70
World Wide Web Consortium (W3C), 216
Worldview, meaning, 882
Written expression, learning disorders in, 562–65
Wundt, Wilhelm, 24–25
X-linked gene, 569
Xanax, 16
K statistic, 283
Yale-Brown Obsessive Compulsive Scale (YBOCS), 327
Yellow Emperor’s Classic of Internal Medicine, 24
Yin and Yang, concepts of, 24
Young-Helmholtz theory of color vision, 25
Youth Mental Health, 215
Zeitgest movement, 99
Ziprasidone (Geodon), 297